The association between LOC124153154 (Sharpr-MPRA Regulatory Region 1462) and Spherocytosis, Type 1 is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources1
Clinical variants19
Symptoms14
Compounds0
Trials0
Publications1
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.